| Name | Walgreens #17742 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 47 Hopatchung Rd, Hopatcong, New Jersey 07843 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (973) 398-5647 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The recombinant anti-CD20 monoclonal antibody produced by LFB Biotechnologies received orphan drug status for the treatment of Chronic Lymphocytic Leukemia (CLL). This approval from the FDA Office of Orphan Products Development was granted on August 6th, 2010.
A heathy diet is linked to better reading skills in the first three school years, shows a recent study from Finland. Published in the European Journal of Nutrition, the study constitutes part of the Physical Activity and Nutrition in Children Study conducted at the University of Eastern Finland and the First Steps Study conducted at the University of Jyväskylä.
The FDA today announced that it will open a public docket to begin receiving public comments on the Institute of Medicine's report on the 510(k) program, the most common pathway to market for lower-risk medical devices.
Advanced cancer patients are successfully able to express their desired level of pain relief on a scale of 1–10, indicating that personalized pain goals could be a novel target for pain treatment response, say researchers.
› Verified 3 days ago
| NPI Number | 1568980506 |
| Organization Name | WALGREEN CO |
| Doing Business As | RITE AID |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 47 Hopatchung Rd, Hopatcong, NJ 07843 |
| Phone Number | 973-398-5647 |
News Archive
The recombinant anti-CD20 monoclonal antibody produced by LFB Biotechnologies received orphan drug status for the treatment of Chronic Lymphocytic Leukemia (CLL). This approval from the FDA Office of Orphan Products Development was granted on August 6th, 2010.
A heathy diet is linked to better reading skills in the first three school years, shows a recent study from Finland. Published in the European Journal of Nutrition, the study constitutes part of the Physical Activity and Nutrition in Children Study conducted at the University of Eastern Finland and the First Steps Study conducted at the University of Jyväskylä.
The FDA today announced that it will open a public docket to begin receiving public comments on the Institute of Medicine's report on the 510(k) program, the most common pathway to market for lower-risk medical devices.
Advanced cancer patients are successfully able to express their desired level of pain relief on a scale of 1–10, indicating that personalized pain goals could be a novel target for pain treatment response, say researchers.
› Verified 3 days ago
| NPI Number | 1982128948 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #17742 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 47 Hopatchung Rd, Hopatcong, NJ 07843 |
| Phone Number | 973-398-5647 |
News Archive
The recombinant anti-CD20 monoclonal antibody produced by LFB Biotechnologies received orphan drug status for the treatment of Chronic Lymphocytic Leukemia (CLL). This approval from the FDA Office of Orphan Products Development was granted on August 6th, 2010.
A heathy diet is linked to better reading skills in the first three school years, shows a recent study from Finland. Published in the European Journal of Nutrition, the study constitutes part of the Physical Activity and Nutrition in Children Study conducted at the University of Eastern Finland and the First Steps Study conducted at the University of Jyväskylä.
The FDA today announced that it will open a public docket to begin receiving public comments on the Institute of Medicine's report on the 510(k) program, the most common pathway to market for lower-risk medical devices.
Advanced cancer patients are successfully able to express their desired level of pain relief on a scale of 1–10, indicating that personalized pain goals could be a novel target for pain treatment response, say researchers.
› Verified 3 days ago
News Archive
The recombinant anti-CD20 monoclonal antibody produced by LFB Biotechnologies received orphan drug status for the treatment of Chronic Lymphocytic Leukemia (CLL). This approval from the FDA Office of Orphan Products Development was granted on August 6th, 2010.
A heathy diet is linked to better reading skills in the first three school years, shows a recent study from Finland. Published in the European Journal of Nutrition, the study constitutes part of the Physical Activity and Nutrition in Children Study conducted at the University of Eastern Finland and the First Steps Study conducted at the University of Jyväskylä.
The FDA today announced that it will open a public docket to begin receiving public comments on the Institute of Medicine's report on the 510(k) program, the most common pathway to market for lower-risk medical devices.
Advanced cancer patients are successfully able to express their desired level of pain relief on a scale of 1–10, indicating that personalized pain goals could be a novel target for pain treatment response, say researchers.
› Verified 3 days ago
Walgreens #17742 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 47 Hopatchung Rd, Hopatcong, New Jersey 07843 Phone: (973) 398-5647 |